Glenmark Pharmaceuticals Limited (NSE:GLENMARK)

India flag India · Delayed Price · Currency is INR
2,205.00
+41.80 (1.93%)
Apr 13, 2026, 3:29 PM IST
Market Cap618.89B +47.5%
Revenue (ttm)165.10B +18.3%
Net Income10.65B
EPS37.74
Shares Out282.20M
PE Ratio58.11
Forward PE27.53
Dividend5.00 (0.23%)
Ex-Dividend Daten/a
Volume724,083
Average Volume659,254
Open2,153.40
Previous Close2,163.20
Day's Range2,115.10 - 2,205.00
52-Week Range1,336.00 - 2,297.90
Beta0.29
RSI56.54
Earnings DateMay 22, 2026

About Glenmark Pharmaceuticals

Glenmark Pharmaceuticals Limited, together with its subsidiaries, develops, manufactures, and sells generics, specialty medicines, and over the counter (OTC) pharmaceutical products in India, North America, Europe, and internationally. The company provides branded, OTC, and generic formulations in the therapeutic areas of dermatology, respiratory, oncology, immunology, pain management, hypertension, central nervous system, cardiology, diabetes, contraceptives, gynecology, gastroenterology, and anti-infective in the dosage forms of complex injec... [Read more]

Sector Healthcare
Founded 1977
Employees 15,800
Stock Exchange National Stock Exchange of India
Ticker Symbol GLENMARK
Full Company Profile

Financial Performance

Financial Statements

News

Glenmark Secures FDA Approval For Progesterone Vaginal Inserts, 100 Mg

(RTTNews) - Glenmark Pharmaceuticals Limited (532296) has received final approval from the U.S. FDA for its Progesterone Vaginal Inserts, 100 mg, marking a new addition to the company's women's health...

3 days ago - Nasdaq

Pharma sector stocks today, April 9: Senores Pharma up 2.48%, Jubilant Pharmova down 2.02%, Glenmark Pharma falls 1.11%

The BSE Healthcare Index opened in positive territory on April 9, rising 0.40% to 42,261.7 even as the broader market slipped — the Sensex was down 0.70% and Nifty 50…

4 days ago - Business Upturn

Glenmark Pharmaceuticals receives U.S. FDA approval for progesterone vaginal inserts

Glenmark Pharmaceuticals Limited has secured final approval from the United States Food & Drug Administration (U.S. FDA) for its Progesterone Vaginal Inserts, 100 mg. The FDA has determined these inse...

4 days ago - Business Upturn

Pharma sector stocks rally sharply today, April 1: Marksans Pharma jumps 6%, Alembic gains 5.37%, Glenmark Pharma surge 4.30%

Indian pharma stocks showed broad-based gains in early trading on April 1, 2026. Many companies in the sector traded higher on both BSE and NSE, even as the broader market…

12 days ago - Business Upturn

Pharma sector stocks today, March 24: Shilpa Medicare jumps 3.28%, Glenmark Pharma up 1.36%, Laurus Labs gain 1.65%

The Indian pharmaceutical sector showed mixed movements in early trading, as of approximately 9:51 AM IST on March 24, 2026. The S&P BSE Healthcare Index stood at 41,630.4, reflecting a…

20 days ago - Business Upturn

Pharma sector stocks today, March 23: Alembic Pharma down 2.24%, Ajanta Pharma falls 1.85%, Glenmark Pharma falls 1.98%

The pharmaceutical sector in India experienced a downturn on March 23, 2026, as reflected in early morning trading data from BSE and NSE around 9:29-9:30 AM IST. Most listed pharma…

21 days ago - Business Upturn

Pharma sector stocks fall today, March 19: Biocon down 2.33%, Laurus Labs falls 2.29%, Glenmark Pharma drops 2%

Pharmaceutical stocks in India experienced a decline on March 19, 2026, during early trading hours. Market data as of approximately 9:46 AM IST (BSE) and 9:49 AM IST (NSE) showed…

25 days ago - Business Upturn

Glenmark Pharmaceuticals launches authorised generic to Savella tablets in the US

Glenmark Pharmaceuticals Inc., USA, a subsidiary of Glenmark Pharmaceuticals Limited, has announced the launch of Milnacipran Hydrochloride Tablets in the US market. These tablets, available in dosage...

25 days ago - Business Upturn

Glenmark Pharmaceuticals receives US FDA approval for Fluticasone Propionate Nasal Spray

Glenmark Pharmaceuticals Limited has announced that it has received final approval from the United States Food & Drug Administration (U.S. FDA) for its Fluticasone Propionate Nasal Spray USP, 50 mcg…

25 days ago - Business Upturn

Pharma sector stocks today, March 16: Suven Life up 3.46%, Glenmark Pharma surge 1.39%, Divis Lab rises 0.36%

The pharmaceutical sector stocks in India showed mixed performance on March 16, 2026, during early trading hours. Data is based on prices as of approximately 9:43 AM IST for BSE…

4 weeks ago - Business Upturn

Pharma sector stocks today, March 11: Natco Pharma falls 1.35%, Alembic Pharma surge 1.33%, Glenmark Pharma up 1.41%

The Pharmaceuticals sector stocks in India showed mixed performance on March 11, 2026, during early trading hours. Data is based on prices as of approximately 9:43 AM IST for BSE…

4 weeks ago - Business Upturn

Pharma sector stocks surge today, March 10: Natco Pharma up 4%, Granules India jumps 3.31%, Glenmark Pharma rises 2.72%

The pharmaceutical sector in India showed positive movement on March 10, 2026, during early trading hours, with many stocks recording gains as of approximately 9:36 AM IST on BSE and…

4 weeks ago - Business Upturn

Pharma sector fall sharply otday, March 9: Laurus Labs down 3%, Glenmark Pharma drops 2.44%, Zydus Life falls 2.10%

The Indian pharmaceutical sector experienced declines on March 9, 2026, amid broader market weakness. As of approximately 9:36-9:39 AM IST, most listed pharma stocks traded lower on both BSE and…

5 weeks ago - Business Upturn

Glenmark Pharma subsidiary gets US FDA approves Fluticasone Propionate inhalation aerosol with 180-day exclusivity

Glenmark Pharmaceuticals is likely to remain in focus after its subsidiary, Glenmark Specialty SA, received final approval from the United States Food and Drug Administration (US FDA) for Fluticasone ...

5 weeks ago - Business Upturn

Glenmark Pharma’s US arm to launch Sodium Phosphates Injection USP

Glenmark Pharmaceuticals Inc., the US arm of Glenmark Pharmaceuticals Ltd., has announced the upcoming launch of Sodium Phosphates Injection USP...

6 weeks ago - Business Upturn

Pharma sector stocks today, Feb 9: Marksans Pharma up 5%, Shilpa Medicare jumps 6%, Glenmark rises 1.83%

The Indian pharma sector showed mixed intraday movements on February 9, 2026, amid broader market gains driven by positive global...

2 months ago - Business Upturn

AcuCort Signs Glenmark Deal To Market Zeqmelit In Six European Countries

(RTTNews) - AcuCort AB (ACUC.ST), a Swedish biotechnology company, on Thursday said it has signed a commercial agreement with Glenmark Pharmaceuticals Ltd. (GLENMARK.NS) for the marketing and distribu...

2 months ago - Nasdaq

Pharma sector stocks fall today: Glenmark Pharma drops 1.38%, Aurobindo Pharma downm 1.25%, Sun Pharma falls 0.87, Dr. Reddy’s Lab down 0.48%

The pharma sector stocks in India experienced declines as of 10 AM on January 20, 2026, aligning with broader market...

2 months ago - Business Upturn

Pharma sector stocks today: Sun Pharma falls 1.20%, Lupin down 1%, Glenmark Pharma rises 0.49%

The Indian pharma sector showed modest downward pressure in early trading on January 14, 2026, as of approximately 9:55 AM...

3 months ago - Business Upturn

Pharma sector stocks today: Glenmark Pharma falls 2.41%, Dr Reddy’s Laboratories down 1.39%, Emcure up 1.70%

The Indian pharma sector displayed mixed performance in early trading on January 13, 2026, as of approximately 9:50 AM IST....

3 months ago - Business Upturn

Glenmark Pharma launches Epinephrine Injection USP multiple-dose vial in the US

Glenmark Pharmaceuticals Inc. has announced the launch of Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) Multiple-Dose Vial in the...

3 months ago - Business Upturn

Top stocks to watch today, December 17: Ola Electric, NBCC, Ahluwalia Contracts, Glenmark Pharma, BEML and more

Indian equity benchmarks are expected to open on a flat note on Wednesday, December 17, 2025, as investors weigh mixed...

4 months ago - Business Upturn

Glenmark Pharma enters licensing deal with Hansoh Pharma for lung cancer drug aumolertinib

Glenmark Pharmaceuticals has taken a major step in strengthening its global oncology portfolio through its wholly owned subsidiary, Glenmark Specialty...

4 months ago - Business Upturn

Glenmark Pharma to launch Leucovorin Calcium for Injection USP, 350 mg/vial in the U.S. market

Glenmark Pharmaceuticals Inc., USA has announced that it is gearing up to launch Leucovorin Calcium for Injection USP, 350 mg/vial...

4 months ago - Business Upturn

Glenmark’s Aurangabad Facility Clears US FDA Inspection With Zero Observations

Glenmark Pharmaceuticals has received a major regulatory boost as the US Food and Drug Administration (US FDA) has successfully completed...

4 months ago - Business Upturn